Conduct of Development. Each party shall conduct its respective obligations under the Development Program for each Product in compliance in all material respects with all requirements of applicable laws and regulations and all applicable good laboratory, clinical and manufacturing practices. Gen-Probe and Novartis each shall proceed diligently with their respective obligations under each such Development Program and shall use their respective Commercially Reasonable Efforts to achieve its objectives efficiently and expeditiously. Gen-Probe and Novartis each shall allocate sufficient personnel, equipment, facilities and other resources to each such Development Program to carry out their respective obligations and to accomplish the objectives thereof.
Appears in 2 contracts
Sources: Restated Agreement (Gen Probe Inc), Restated Agreement (Gen Probe Inc)